Furthermore, Gas6/Axl is suggested to positively regulate the expression of the tumor suppressor LIGHT (lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator (HVEM) on T cells mediating an anti-oncogenic trait) which induces robust anti-tumor immunity [99]. The gene discussed is GAS6; the disease is neoplasm.